Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Washington University, Medical College of Wisconsin, and More

Premium

NIH Grants in Proteomics, Oct. 25 to May 1, Part 2 of 3 (Click for Part 1 and Part 3.)

Project Title: Proteomics
Contact Principal Investigator: Kari Green
Organization Name: Ohio State University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $97,018


Project Title: A Resource for Biomedical Mass Spectrometry
Contact Principal Investigator: Michael Gross
Organization Name: Washington University
Project Start Date: Aug. 1, 1997
Project End Date: Dec. 31, 2014
FY Total Cost: $1,309,708


Project Title: Proteomics Facility Core
Contact Principal Investigator: Peter Guengerich
Organization Name: Vanderbilt University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $140,492


Project Title: Global Characterization of Ubiquitin Information Networks with Mass Spectrometry
Contact Principal Investigator: Steven Gygi
Organization Name: Harvard University Medical School
Project Start Date: May 15, 2003
Project End Date: Feb. 28, 2017
FY Total Cost: $494,852


Project Title: The Leptospiral Outer Membrane Proteome & Immunity
Contact Principal Investigator: David Haake
Organization Name: VA Greater Los Angels Healthcare System
Project Start Date: Jan. 1, 2014
Project End Date: Dec. 31, 2017
FY Total Cost: NA


Project Title: Targeted Proteomic Approaches for Natural Product Biosynthetic Pathway Discovery
Contact Principal Investigator: Kristina Hakansson
Organization Name: University of Michigan at Ann Arbor
Project Start Date: Feb. 1, 2014
Project End Date: Jan. 31, 2019
FY Total Cost: $280,026


Project Title: Research Support Core: Proteome Response to Toxic Perturbation
Contact Principal Investigator: Bruce Hammock
Organization Name: University of California at Davis
Project Start Date: NA
Project End Date: NA
FY Total Cost: $273,687


Project Title: Astrocyte Secretome: Ability to Modify Phenotype and Genotype of Cells Within CNS
Contact Principal Investigator: David Harder
Organization Name: Medical College of Wisconsin
Project Start Date: April 1, 1985
Project End Date: March 31, 2018
FY Total Cost: $382,500


Project Title: Activity-Based Kinase Discovery in Small Cell Lung Cancer
Contact Principal Investigator: Eric Haura
Organization Name: H. Lee Moffitt Cancer Center & Research Institute
Project Start Date: April 1, 2013
Project End Date: March 31, 2015
FY Total Cost: $182,868


Project Title: A Molecular Toolkit for Single-Molecule Protein Sequencing
Contact Principal Investigator: James Havranek
Organization Name: Washington University
Project Start Date: June 1, 2012
Project End Date: March 31, 2017
FY Total Cost: $288,800


Project Title: Core F: Quantitative and Functional Proteomics Core
Contact Principal Investigator: Jay Heinecke
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $217,933


Project Title: Proteogenomic Analysis of Inflammation and Dysbiosis in the Infant Gut
Contact Principal Investigator: Robert Hettich
Organization Name: UT-Battelle, LLC-Oak Ridge National Lab
Project Start Date: Feb. 6, 2014
Project End Date: Nov. 30, 2017
FY Total Cost: $370,486


Project Title: Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network
Contact Principal Investigator: Robert Husson
Organization Name: Children's Hospital Corporation
Project Start Date: April 16, 2012
Project End Date: March 31, 2017
FY Total Cost: $1,214,907


Project Title: Targeting C-Src in Head and Neck Cancer
Contact Principal Investigator: Faye Johnson
Organization Name: UT MD Anderson Cancer Center
Project Start Date: Jan. 1, 2010
Project End Date: Dec. 31, 2014
FY Total Cost: $242,327


Project Title: Proteomics Core Facility
Contact Principal Investigator: John Kooman
Organization Name: H. Lee Moffitt Cancer Center & Research Institute
Project Start Date: NA
Project End Date: NA
FY Total Cost: $91,273


Project Title: Stress Signaling Pathways and Resistance in Colorectal Cancer
Contact Principal Investigator: Scott Kopetz
Organization Name: UT MD Anderson Cancer Center
Project Start Date: Jan. 18, 2013
Project End Date: Dec. 31, 2017
FY Total Cost: $306,625


Project Title: Cerebrospinal Fluid Proteome Mediated Signaling in the Developing CNS
Contact Principal Investigator: Maria Lehtinen
Organization Name: Children's Hospital Corporation
Project Start Date: Sept. 30, 2010
Project End Date: Dec. 31, 2014
FY Total Cost: $240,632


Project Title: Signaling by Growth Factor Receptors with Intracellular Pseudokinase Domains
Contact Principal Investigator: Mark Lemmon
Organization Name: University of Pennsylvania
Project Start Date: Feb. 3, 2012
Project End Date: Nov. 30, 2015
FY Total Cost: $399,157


Project Title: Proteomics Core
Contact Principal Investigator: Caryn Lerman
Organization Name: University of Pennsylvania
Project Start Date: NA
Project End Date: NA
FY Total Cost: $203,134


Project Title: Project 1 - Renewal of the UMDNJ Neuroproteomics Core Facility
Contact Principal Investigator: Hong Li
Organization Name: Rutgers Biomedical and Health Sciences - New Jersey Medical School
Project Start Date: July 1, 2003
Project End Date: Nov. 30, 2014
FY Total Cost: $693,308


Project Title: Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption
Contact Principal Investigator: Suthat Liangpunsakul
Organization Name: Richard L. Roudebush VA Medical Center
Project Start Date: Oct. 1, 2011
Project End Date: Sept. 30, 2015
FY Total Cost: NA


Project Title: Cancer Proteomics
Contact Principal Investigator: Towia Libermann
Organization Name: Dana-Farber Cancer Institute
Project Start Date: NA
Project End Date: NA
FY Total Cost: $244,883


Project Title: Bioanalytical Laboratory
Contact Principal Investigator: Mark Lively
Organization Name: Wake Forest University Health Sciences
Project Start Date: NA
Project End Date: NA
FY Total Cost: $76,352


Project Title: Lipoproteins and Inflammation in the Development of Diabetic Complications
Contact Principal Investigator: Maria Lopes-Virella
Organization Name: Ralph H Johnson VA Medical Center
Project Start Date: Oct. 1, 2013
Project End Date: Sept. 30, 2017
FY Total Cost: NA


Project Title: Biomolecular Mass Spectrometry Facility Core
Contact Principal Investigator: Claudia Maier
Organization Name: Oregon State University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $212,645


Project Title: Modification of Host Proteins During Chlamydia Infection
Contact Principal Investigator: Christine Mcbeth
Organization Name: Harvard University Medical School
Project Start Date: Feb. 1, 2012
Project End Date: Jan. 31, 2015
FY Total Cost: $56,978


Project Title: Modeling Response to PI3k Target Therapies
Contact Principal Investigator: Gordon Mills
Organization Name: Oregon Health & Science University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $400,864


Project Title: Modeling Response to PI3k Targeted Therapies
Contact Principal Investigator: Gordon Mills
Organization Name: Oregon Health & Science University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $30,601


Project Title: P-1: Molecular Signatures for Individualizing Lung Cancer Therapy
Contact Principal Investigator: John Minna
Organization Name: UT Southwestern Medical Center
Project Start Date: Sept. 12, 2013
Project End Date: Aug. 31, 2014
FY Total Cost: $156,620


Project Title: Characterization of the Mitochondrial Proteome
Contact Principal Investigator: Vamsi Mootha
Organization Name: Broad Institute
Project Start Date: Feb. 1, 2007
Project End Date: Feb. 28, 2017
FY Total Cost: $518,358


Project Title: Proteomics
Contact Principal Investigator: Arthur Moseley
Organization Name: Duke University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $41,298


Project Title: Posttranscriptional Regulation of TNFA by CARM1 in Macrophages
Contact Principal Investigator: Kerri Mowen
Organization Name: Scripps Research Institute
Project Start Date: Dec. 20, 2013
Project End Date: Nov. 30, 2015
FY Total Cost: $255,825


Project Title: Role of Chaperones in Maintaining the Asparagine Repeat-Rich Proteome of P. Falci
Contact Principal Investigator: Vasant Muralidharan
Organization Name: University of Georgia
Project Start Date: May 1, 2012
Project End Date: Jan. 31, 2015
FY Total Cost: $249,000


Project Title: Determining Molecular and Cellular Mechanisms of Glaucoma
Contact Principal Investigator: Kayarat Nair
Organization Name: University of California, San Francisco
Project Start Date: Feb. 1, 2014
Project End Date: Jan. 31, 2018
FY Total Cost: $354,562


Project Title: Elucidating the Role of TIN2L at the Telomere and in Dyskeratosis Congenita
Contact Principal Investigator: Nya Nelson
Organization Name: Baylor College of Medicine
Project Start Date: April 1, 2012
Project End Date: May 31, 2015
FY Total Cost: $44,008


Project Title: Population-Based Proteomic Investigation of Type 2 Diabetes Mellitus
Contact Principal Investigator: Randall Nelson
Organization Name: Arizona State University-Tempe Campus
Project Start Date: March 1, 2010
Project End Date: Feb. 28, 2015
FY Total Cost: $523,481


Project Title: Molecular Mechanisms of Synapse Assembly and Function
Contact Principal Investigator: Kathaleen O'connor-Giles
Organization Name: University of Wisconsin-Madison
Project Start Date: May 1, 2013
Project End Date: April 30, 2018
FY Total Cost: $19,159


Project Title: Cell Surface Proteome of Monocytes Latently Infected with Human Cytomegalovirus
Contact Principal Investigator: Adam Oberstein
Organization Name: Princeton University
Project Start Date: Feb. 1, 2014
Project End Date: Jan. 31, 2017
FY Total Cost: $55,094


Project Title: Phosphoproteomic Tools for Synaptic vs. Extrasynaptic NMDA Receptor Signaling
Contact Principal Investigator: Shu-Ichi Okamoto
Organization Name: Sanford-Burnham Medical Research Institute
Project Start Date: Jan. 10, 2014
Project End Date: Dec. 31, 2015
FY Total Cost: $292,500


Project Title: Comprehensive Identification of CDK8 Kinase Targets Using Silac Phosphoproteomics
Contact Principal Investigator: William Old
Organization Name: University of Colorado
Project Start Date: Jan. 1, 2014
Project End Date: Dec. 31, 2015
FY Total Cost: $161,057


Project Title: Understanding Mechanisms in Specific Immunotherapy
Contact Principal Investigator: Bjoern Peters
Organization Name: La Jolla Institute for Allergy & Immunology
Project Start Date: NA
Project End Date: NA
FY Total Cost: $304,399


Project Title: Development of Lewy Bodies Biofluid Signatures by Targeted Proteomics
Contact Principal Investigator: Vladislav Petyuk
Organization Name: Battelle Pacific Northwest Laboratories
Project Start Date: Sept. 30, 2012
Project End Date: Jan. 31, 2016
FY Total Cost: $336,955


Project Title: Microparticle Capture-Based Analysis of Lymph Node Proteome
Contact Principal Investigator: Serguei Popov,
Organization Name: George Mason University
Project Start Date: April 15, 2013
Project End Date: March 31, 2015
FY Total Cost: $220,875


Project Title: Core D
Contact Principal Investigator: Scott Powers,
Organization Name: Cold Spring Harbor Laboratory
Project Start Date: NA
Project End Date: NA
FY Total Cost: $402,866


Project Title: Proteomics
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $201,442

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.